| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 30,0 M € | +6.3% | 28,2 M € | +10.0% | 25,6 M € | +10.9% | 23,1 M € | +4.5% | 22,1 M € | +13.6% | 19,5 M € | +5.2% | 18,5 M € | -15.1% | 21,8 M € | -6.0% | 23,2 M € | +8.9% | 21,3 M € | +8.0% | 19,7 M € | +12.8% | 17,5 M € | +17.6% | 14,9 M € | +9.3% | 13,6 M € | +24.6% | 10,9 M € | +23.8% | 8,8 M € | +7.0% | 8,2 M € | — | — | — | ||||
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2,3 M € | +19.7% | 1,9 M € | +34.9% | 1,4 M € | ||||||||||||||||||
| EBITDA | 1,5 M € | +4.1% | 1,5 M € | -21.3% | 1,8 M € | -9.5% | 2,0 M € | +6.7% | 1,9 M € | +9.6% | 1,7 M € | +26.3% | 1,4 M € | -72.0% | 4,9 M € | +123.2% | 2,2 M € | +16.6% | 1,9 M € | -15.4% | 2,2 M € | +6.2% | 2,1 M € | +26.6% | 1,7 M € | -49.5% | 3,3 M € | +30.2% | 2,5 M € | +29.8% | 2,0 M € | +11.1% | 1,8 M € | +27.2% | 1,4 M € | +24.3% | 1,1 M € | +56.7% | 710,7 k € | |
| Operating profit | 1,4 M € | +4.9% | 1,4 M € | -28.7% | 1,9 M € | -3.9% | 2,0 M € | +12.4% | 1,8 M € | +3.9% | 1,7 M € | +24.6% | 1,4 M € | -72.2% | 4,9 M € | +132.7% | 2,1 M € | +14.0% | 1,9 M € | -16.0% | 2,2 M € | +5.4% | 2,1 M € | +28.7% | 1,6 M € | -50.9% | 3,3 M € | +34.9% | 2,5 M € | +26.5% | 2,0 M € | +16.0% | 1,7 M € | +29.3% | 1,3 M € | +87.2% | 695,7 k € | +5168.2% | 13,2 k € | |
| Profit/loss | 1,0 M € | +6.1% | 965,7 k € | -30.3% | 1,4 M € | -3.5% | 1,4 M € | -7.7% | 1,6 M € | +13.8% | 1,4 M € | +48.5% | 919,8 k € | -73.2% | 3,4 M € | +156.5% | 1,3 M € | +12.0% | 1,2 M € | -17.3% | 1,4 M € | +4.6% | 1,4 M € | +28.2% | 1,1 M € | -50.6% | 2,2 M € | +34.3% | 1,6 M € | +25.9% | 1,3 M € | +10.8% | 1,2 M € | -0.4% | 1,2 M € | +105.2% | 570,7 k € | +659.9% | -101,9 k € | |
| Equity | 8,8 M € | +0.3% | 8,7 M € | -10.6% | 9,8 M € | +4.1% | 9,4 M € | -0.7% | 9,4 M € | +7.4% | 8,8 M € | +5.6% | 8,3 M € | -22.9% | 10,8 M € | +46.6% | 7,4 M € | +22.2% | 6,0 M € | +3.4% | 5,8 M € | +8.3% | 5,4 M € | +7.7% | 5,0 M € | +1.6% | 4,9 M € | +25.0% | 3,9 M € | +19.0% | 3,3 M € | +64.1% | 2,0 M € | +14.9% | 1,8 M € | +200.4% | 584,5 k € | +4134.4% | 13,8 k € | |
| Total assets | 16,7 M € | +18.4% | 14,1 M € | -2.2% | 14,4 M € | +19.5% | 12,0 M € | -12.1% | 13,7 M € | +14.3% | 12,0 M € | -0.4% | 12,0 M € | -3.4% | 12,5 M € | +1.4% | 12,3 M € | +41.7% | 8,7 M € | +1.9% | 8,5 M € | +1.5% | 8,4 M € | +13.5% | 7,4 M € | +21.9% | 6,1 M € | +7.7% | 5,6 M € | +25.3% | 4,5 M € | +12.8% | 4,0 M € | -2.3% | 4,1 M € | +18.3% | 3,5 M € | +8.3% | 3,2 M € | |
| Cash | 492,0 k € | -74.3% | 1,9 M € | +24.0% | 1,5 M € | -65.2% | 4,4 M € | +60.9% | 2,8 M € | -3.7% | 2,9 M € | -28.0% | 4,0 M € | +3.8% | 3,8 M € | +408.2% | 753,3 k € | -0.6% | 758,2 k € | +39.8% | 542,4 k € | -27.0% | 743,1 k € | -49.6% | 1,5 M € | +57.1% | 938,5 k € | -10.6% | 1,1 M € | -16.4% | 1,3 M € | +103.4% | 617,5 k € | -5.6% | 654,1 k € | +35.3% | 483,4 k € | +45.0% | 333,4 k € | |
| Debts | 7,9 M € | +48.2% | 5,3 M € | +15.6% | 4,6 M € | +74.1% | 2,6 M € | -37.6% | 4,2 M € | +33.1% | 3,2 M € | -14.0% | 3,7 M € | +124.4% | 1,7 M € | -66.4% | 4,9 M € | +86.3% | 2,6 M € | -1.5% | 2,7 M € | -10.8% | 3,0 M € | +25.6% | 2,4 M € | +108.9% | 1,1 M € | -32.4% | 1,7 M € | +42.8% | 1,2 M € | -39.8% | 2,0 M € | -12.1% | 2,2 M € | -18.4% | 2,7 M € | -10.2% | 3,1 M € | |
| Staff | 25,1 | 24,1 | 21,1 | 18,5 | 19,6 | 21,6 | 20,1 | 17,2 | 16,8 | 21,6 | 18,5 | 17,2 | 16,8 | 10,3 | 8,9 | 6,3 | 5,5 | 5,6 | 4,9 | 4,9 | ||||||||||||||||||||
Public limited company · Gent · incorporated on 10/05/2000 · 25,1 ETP
Public limited company profitable and well capitalised. Cash position declining (-74.3%).
Solid counterparty for a standard engagement.
THEA PHARMA is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 25,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette